1. Home
  2. LITB vs XLO Comparison

LITB vs XLO Comparison

Compare LITB & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

HOLD

Current Price

$3.01

Market Cap

60.1M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.60

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
XLO
Founded
2007
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.1M
49.8M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
LITB
XLO
Price
$3.01
$8.60
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
10.6K
26.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
$14.50
N/A
Revenue Next Year
$11.59
$168.77
P/E Ratio
$10.96
N/A
Revenue Growth
N/A
589.88
52 Week Low
$1.11
$0.46
52 Week High
$4.17
$9.30

Technical Indicators

Market Signals
Indicator
LITB
XLO
Relative Strength Index (RSI) 49.44 61.50
Support Level $2.41 $7.47
Resistance Level $3.89 $8.97
Average True Range (ATR) 0.17 0.49
MACD -0.08 0.07
Stochastic Oscillator 27.81 74.99

Price Performance

Historical Comparison
LITB
XLO

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: